What happened
Cell Bio Human Tech reported consolidated results for FY2025: revenue of US$35M (+79.69% year on year), operating profit of US$6.44M (+132.63% year on year) and net income of US$5.6M (+86.51% year on year).
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$35M |
|---|---|
| Revenue vs a year earlier | +79.69% |
| Operating profit | US$6.44M |
| Net income | US$5.6M |
| Period | FY2025 (consolidated) |
| Filed | 2026-02-10, Change of 30% or more in revenue or profit/loss structure (15% for large companies) |
| Source | DART rcept 20260210900758 → open original filing |
Source: DART. Information only, not investment advice.